Kenton Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KENTON, and what generic and branded alternatives to KENTON drugs are available?
KENTON has five approved drugs.
Summary for Kenton
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Kenton
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kenton | RILUZOLE | riluzole | TABLET;ORAL | 206045-001 | Dec 9, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Kenton | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 040644-001 | May 30, 2006 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Kenton | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-001 | Apr 24, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Kenton | REPAGLINIDE | repaglinide | TABLET;ORAL | 091517-002 | Apr 24, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
